AVITA Medical Inc (RCEL)
8.66
+0.26
(+3.10%)
USD |
NASDAQ |
May 01, 16:00
8.66
0.00 (0.00%)
After-Hours: 18:36
AVITA Medical Enterprise Value: 166.69M for April 30, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 30, 2024 | 166.69M |
| April 29, 2024 | 174.92M |
| April 26, 2024 | 169.78M |
| April 25, 2024 | 164.12M |
| April 24, 2024 | 171.06M |
| April 23, 2024 | 181.60M |
| April 22, 2024 | 170.55M |
| April 19, 2024 | 172.86M |
| April 18, 2024 | 178.77M |
| April 17, 2024 | 191.88M |
| April 16, 2024 | 200.11M |
| April 15, 2024 | 193.94M |
| April 12, 2024 | 204.74M |
| April 11, 2024 | 216.82M |
| April 10, 2024 | 321.96M |
| April 09, 2024 | 335.58M |
| April 08, 2024 | 339.70M |
| April 05, 2024 | 346.38M |
| April 04, 2024 | 339.44M |
| April 03, 2024 | 339.95M |
| April 02, 2024 | 342.01M |
| April 01, 2024 | 350.49M |
| March 28, 2024 | 362.83M |
| March 27, 2024 | 374.92M |
| March 26, 2024 | 361.81M |
| Date | Value |
|---|---|
| March 25, 2024 | 358.59M |
| March 22, 2024 | 354.09M |
| March 21, 2024 | 365.40M |
| March 20, 2024 | 365.92M |
| March 19, 2024 | 363.09M |
| March 18, 2024 | 357.69M |
| March 15, 2024 | 373.12M |
| March 14, 2024 | 379.03M |
| March 13, 2024 | 390.08M |
| March 12, 2024 | 387.77M |
| March 11, 2024 | 373.37M |
| March 08, 2024 | 391.11M |
| March 07, 2024 | 388.03M |
| March 06, 2024 | 373.63M |
| March 05, 2024 | 390.60M |
| March 04, 2024 | 401.65M |
| March 01, 2024 | 415.02M |
| February 29, 2024 | 416.82M |
| February 28, 2024 | 384.43M |
| February 27, 2024 | 421.44M |
| February 26, 2024 | 421.19M |
| February 23, 2024 | 390.34M |
| February 22, 2024 | 388.03M |
| February 21, 2024 | 398.05M |
| February 20, 2024 | 402.68M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
29.23M
Minimum
Oct 14 2022
23.29B
Maximum
Feb 19 2020
2.172B
Average
355.76M
Median
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 978.51M |
| Retractable Technologies Inc | -13.49M |
| Xtant Medical Holdings Inc | 132.57M |
| Asensus Surgical Inc | 46.00M |
| Catheter Precision Inc | 0.776M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.065M |
| Revenue (Quarterly) | 14.20M |
| Total Expenses (Quarterly) | 26.47M |
| EPS Diluted (Quarterly) | -0.28 |
| Gross Profit Margin (Quarterly) | 87.35% |
| Profit Margin (Quarterly) | -49.77% |
| Earnings Yield | -16.17% |
| Normalized Earnings Yield | -16.17 |